Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice.

MLA

Bi, Youkun, et al. “Bone Marrow Derived-Mesenchymal Stem Cell Improves Diabetes-Associated Fatty Liver via Mitochondria Transformation in Mice.” Stem Cell Research & Therapy, vol. 12, no. 1, Dec. 2021, p. 602. EBSCOhost, https://doi.org/10.1186/s13287-021-02663-5.

APA

Bi, Y., Guo, X., Zhang, M., Zhu, K., Shi, C., Fan, B., Wu, Y., Yang, Z., & Ji, G. (2021). Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice. Stem Cell Research & Therapy, 12(1), 602. https://doi.org/10.1186/s13287-021-02663-5

Chicago

Bi, Youkun, Xuejun Guo, Mengqi Zhang, Keqi Zhu, Chentao Shi, Baoqi Fan, Yanyun Wu, Zhiguang Yang, and Guangju Ji. 2021. “Bone Marrow Derived-Mesenchymal Stem Cell Improves Diabetes-Associated Fatty Liver via Mitochondria Transformation in Mice.” Stem Cell Research & Therapy 12 (1): 602. doi:10.1186/s13287-021-02663-5.